Join the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More informationEMA - Human Medicines Newsletter, January 23
EMA - SME Newsletter Jan 2023
FDA Draft Guidance for Industry on Statistical Approaches for Assessing Bioequivalence
FDA have signed an Agreement on Mutual Recognition between the Swiss Confederation and the United States of America Relating to Pharmaceutical Good Manufacturing Practice.
MHRA - Horizon Scanning Case Study
MHRA increases UK assessment capacity for in-vitro diagnostic devices
MHRA - Professor Tom Clutton-Brock MBE new Chair of the Interim Devices Working Group
The European Commission (EC), the Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) have published recommendations that aim to facilitate the conduct of decentralised clinical trials (DCTs) while safeguarding the rights and well-being of participants as well as the robustness and reliability of the data collected. This is an outcome of their joint initiative to Accelerate Clinical Trials in the European Union (ACT EU).
The EMA are holding a virtual public CTIS event “CTIS Event on Readiness for mandatory use of the Clinical Trials Regulation from 31 January 2023”.
EMA - Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 December 2022